Litigation Details for Journey Medical Corporation v. Perrigo Pharma International DAC (D. Del. 2020)
✉ Email this page to a colleague
Journey Medical Corporation v. Perrigo Pharma International DAC (D. Del. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-10-21 |
| Court | District Court, D. Delaware | Date Terminated | 2022-05-19 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | None | Referred To | Jennifer L. Hall |
| Patents | 10,004,717; 10,052,267; 10,543,192; 10,548,875; 8,618,160; 8,859,610; 9,259,414; 9,744,105 | ||
| Attorneys | Dominick T. Gattuso | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Journey Medical Corporation v. Perrigo Pharma International DAC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Journey Medical Corporation v. Perrigo Pharma International DAC (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-10-21 | 1 | Complaint | the ’267 patent”); 8,859,610 (“the ’610 patent”); 9,259,414 (“the ’414 patent”); 10,004,717 (“the ’717…expiration of U.S. Patent Nos. 8,618,160 (“the ’160 patent”); 9,744,105 (“the ’105 patent”); 10,052,267 (…717 patent”); 10,543,192 (“the ’192 patent”); and 10,548,875 (“the ’875 patent”) (collectively “the … 1. This is an action for patent infringement under the patent laws of the United States, Title…Asserted Patents. Upon information and belief, Perrigo deliberately challenged Plaintiffs’ patent rights | External link to document |
| 2022-05-19 | 93 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,543,192 B2; 10,548,875 B2;… 2020 19 May 2022 1:20-cv-01413 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
